ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 910

$462K Total Retail Price of All Prescriptions

Rank: 204 out of 910

448 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 5,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 336 271 1 1
LISINOPRIL 323 271 2 2
SIMVASTATIN 267 193 3 3
OMEPRAZOLE 223 192 4 5
GABAPENTIN 212 147 5 13
ATENOLOL 206 187 6 10
AMLODIPINE BESYLATE 180 162 7 4
METFORMIN HCL 165 121 8 6
WARFARIN SODIUM 154 101 9 11
TRAMADOL HCL 144 105 10 25
FUROSEMIDE 138 112 11 9
HYDROCODONE-ACETAMINOPHEN 124 98 S3 12 8
METOPROLOL SUCCINATE 119 91 13 21
LANTUS 112 72 14 30
FLUTICASONE PROPIONATE 112 74 14 23
PANTOPRAZOLE SODIUM 112 68 14 27
LOVASTATIN 108 91 17 20
PRAVASTATIN SODIUM 93 62 18 16
METOPROLOL TARTRATE 89 68 19 7
INSULIN SYRINGE 87 58 20 47
CRESTOR 84 78 21 26
CITALOPRAM HBR 78 39 22 19
NIFEDIPINE ER 77 65 23 107
LOSARTAN POTASSIUM 76 60 24 15
GLYBURIDE 76 72 R 24 46
RANITIDINE HCL 70 70 26 28
HYDROCHLOROTHIAZIDE 68 59 27 12
SPIRONOLACTONE 68 46 27 66
JANUVIA 66 66 29 69
POLYETHYLENE GLYCOL 3350 63 53 30 104
GLIMEPIRIDE 63 50 30 56
CLOPIDOGREL 62 51 32 35
ADVAIR DISKUS 59 42 33 45
CARVEDILOL 58 38 34 36
TAMSULOSIN HCL 56 45 35 29
PROAIR HFA 55 42 36 40
FENOFIBRATE 55 22 36 55
NOVOLOG 53 21 38 78
ATORVASTATIN CALCIUM 52 42 39 14
POTASSIUM CHLORIDE 52 47 39 18
ZOLPIDEM TARTRATE 51 40 41 17
DONEPEZIL HCL 50 44 42 32
HYDRALAZINE HCL 50 29 42 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.